Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA-directed RNA polymerase III subunit G (POLR3G) is a peripheral subunit of RNA polymerase III, the multi-subunit enzyme complex responsible for the transcription of small noncoding RNAs, including tRNAs, 5S rRNA, and snRNAs[2][3][5]. POLR3G (also known as RPC7-alpha) is incorporated into one of two alternative Pol III complexes in a mutually exclusive manner with its paralog POLR3GL (RPC7-beta). This subunit is essential for assembly and function of the Pol III-specific heterotrimer required for transcription initiation and interacts with transcription factors such as TFIIIB[1][3]. POLR3G is highly expressed in embryonic stem cells and many cancers, where its upregulation is linked to expanded transcriptional output of specific small RNAs and poor prognosis[3][4]. It also acts as a nuclear and cytosolic DNA sensor, contributing to the innate immune response to intracellular pathogens by mediating the production of RNA that can activate immune signaling pathways[2]. POLR3G is not a current drug target and does not have known direct small-molecule modulators; however, its expression is being explored as a biomarker and potential therapeutic vulnerability in oncology[3][4]. Loss of POLR3G function in animal models results in early embryonic lethality, underscoring its essential role in development[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA-directed RNA polymerase III subunit G (POLR3G).